Consumer & Healthcare

Asics sees boom in running shoes for India’s healthy and wealthy

Demand for its top-end Onitsuka Tiger sportswear label accounts for about 15% of total revenue

Luckin has expanded with more than 29,000 stores offering low-cost coffee and other customised drinks such as coconut or cheese lattes.

Luckin Coffee’s PE owner gains more control over Chinese chain

The company’s American depositary receipts have gained 24% in the past 12 months

Kirin has said that it wants its health business to make up 20% of total sales as soon as 2030.

Japan’s Kirin sells Four Roses bourbon as US whisky market cools

Concerns over the impact of US President Donald Trump’s tariffs also continue to weigh on the sector

In September 2025, GSK said that Luke Miels (above) would replace Emma Walmsley as chief executive officer.

GSK profit lifted by HIV, asthma drugs in boost to new CEO

Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations

“We are exploring other markets that could pay better,” association head Robert Young says.

Philippine garment makers find they can’t quit the US just yet

Long-standing relationships built over decades with American clients have helped to soften the blow

Rajput abruptly stepped down from his position at Biofourmis Holdings in August 2023.

Former Biofourmis CEO to be charged over alleged fraud and falsified invoices worth US$16.5 million

BT understands the accused to be the healthcare startup’s founder and former chief executive Kuldeep Singh Rajput

Luckin Coffee, China’s biggest coffee chain, has already reduced the share of products priced at 9.9 yuan, according to local media reports.

China’s delivery price war starts to cool after regulatory probe

Chinese regulators have heightened scrutiny of the retail sector since 2025

The Exchange Square Complex, which houses the Hong Kong Stock Exchange. In January 2026, initial public offerings and second listings raised about US$5.5 billion in Hong Kong.

Chinese energy drink maker Eastroc fails to pop in subdued Hong Kong debut

It makes functional beverages, which are drinks formulated with added ingredients such as electrolytes or vitamins

FineToday was created in 2021 after Shiseido carved out its personal-care unit and sold it to CVC in a 160 billion yen deal.

CVC to sell personal care business FineToday to Bain Capital in 200 billion yen deal: source

The sale comes a few months after FineToday’s second attempt to list on the Tokyo Stock Exchange failed in October